These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30305662)

  • 1. Predilection of Low Protein C-induced Spontaneous Atherothrombosis for the Right Coronary Sinus in Apolipoprotein E deficient mice.
    Heestermans M; Ouweneel AB; Hassan J; Kloosterman M; Reitsma PH; Gijbels MJJ; van Vlijmen BJM; van Eck M
    Sci Rep; 2018 Oct; 8(1):15106. PubMed ID: 30305662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of Anticoagulant Protein C Evokes Low-Incident but Spontaneous Atherothrombosis in Apolipoprotein E-Deficient Mice-Brief Report.
    Ouweneel AB; Heestermans M; Verwilligen RAF; Gijbels MJJ; Reitsma PH; Van Eck M; van Vlijmen BJM
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):782-785. PubMed ID: 28302625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherothrombosis model by silencing of protein C in APOE*3-Leiden.CETP transgenic mice.
    Jongejan YK; Eikenboom JCJ; Gijbels MJJ; Berbée JFP; van Vlijmen BJM
    J Thromb Thrombolysis; 2021 Oct; 52(3):715-719. PubMed ID: 34052976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XI regulates pathological thrombus formation on acutely ruptured atherosclerotic plaques.
    van Montfoort ML; Kuijpers MJ; Knaup VL; Bhanot S; Monia BP; Roelofs JJ; Heemskerk JW; Meijers JC
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1668-73. PubMed ID: 24947525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced stabilization of atherosclerotic plaques in apolipoprotein E-knockout mice by combinatorial Toll-like receptor-1 and -2 gene silencing.
    Qi LH; Wang Y; Gao F; Zhang C; Ding SF; Ni M; Feng JB; Zhang Y
    Hum Gene Ther; 2009 Jul; 20(7):739-50. PubMed ID: 19278303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor XII regulates the pathological process of thrombus formation on ruptured plaques.
    Kuijpers MJ; van der Meijden PE; Feijge MA; Mattheij NJ; May F; Govers-Riemslag J; Meijers JC; Heemskerk JW; Renné T; Cosemans JM
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1674-80. PubMed ID: 24855058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-JNK2 peptide-siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice.
    Pan H; Palekar RU; Hou KK; Bacon J; Yan H; Springer LE; Akk A; Yang L; Miller MJ; Pham CT; Schlesinger PH; Wickline SA
    Int J Nanomedicine; 2018; 13():5187-5205. PubMed ID: 30233180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of tissue factor induced atherothrombosis in apolipoprotein E-/- mice via both enhanced plaque thrombogenicity and plaque instability.
    Liu X; Ma J; Ma L; Liu F; Zhang C; Zhang Y; Ni M
    J Mol Cell Cardiol; 2019 Feb; 127():1-10. PubMed ID: 30500376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous atherothrombosis and medial degradation in Apoe-/-, Npc1-/- mice.
    Welch CL; Sun Y; Arey BJ; Lemaitre V; Sharma N; Ishibashi M; Sayers S; Li R; Gorelik A; Pleskac N; Collins-Fletcher K; Yasuda Y; Bromme D; D'Armiento JM; Ogletree ML; Tall AR
    Circulation; 2007 Nov; 116(21):2444-52. PubMed ID: 17984379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic treatment with acetylsalicylic acid and clopidogrel on atheroprogression and atherothrombosis in ApoE-deficient mice in vivo.
    Schulz C; Konrad I; Sauer S; Orschiedt L; Koellnberger M; Lorenz R; Walter U; Massberg S
    Thromb Haemost; 2008 Jan; 99(1):190-5. PubMed ID: 18217153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of sirtuin 6 accelerates endothelial dysfunction and atherosclerosis in apolipoprotein E-deficient mice.
    Liu Z; Wang J; Huang X; Li Z; Liu P
    Transl Res; 2016 Jun; 172():18-29.e2. PubMed ID: 26924042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice.
    Fraga-Silva RA; Montecucco F; Costa-Fraga FP; Nencioni A; Caffa I; Bragina ME; Mach F; Raizada MK; Santos RAS; da Silva RF; Stergiopulos N
    Vascul Pharmacol; 2015 Nov; 74():103-113. PubMed ID: 26304699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
    Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and pharmacological modifications of thrombin formation in apolipoprotein e-deficient mice determine atherosclerosis severity and atherothrombosis onset in a neutrophil-dependent manner.
    Borissoff JI; Otten JJ; Heeneman S; Leenders P; van Oerle R; Soehnlein O; Loubele ST; Hamulyák K; Hackeng TM; Daemen MJ; Degen JL; Weiler H; Esmon CT; van Ryn J; Biessen EA; Spronk HM; ten Cate H
    PLoS One; 2013; 8(2):e55784. PubMed ID: 23409043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice.
    Calara F; Silvestre M; Casanada F; Yuan N; Napoli C; Palinski W
    J Pathol; 2001 Sep; 195(2):257-63. PubMed ID: 11592107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
    Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
    Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
    Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuated atherogenesis in apolipoprotein E-deficient mice lacking amyloid precursor protein.
    Van De Parre TJ; Guns PJ; Fransen P; Martinet W; Bult H; Herman AG; De Meyer GR
    Atherosclerosis; 2011 May; 216(1):54-8. PubMed ID: 21316678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
    Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D
    J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.